Skip to Main Content

Paper Details

Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells.
Oncotarget
28
2016
BTIC, BTIC lines, BTICs, DEX, EZH2, GBM, Glioblastoma, HDAC, TMZ, UNC1999, brain tumor, brain-tumor, class I HDAC, dexamethasone, glioblastoma brain tumor, glioblastoma brain tumor-initiating cells, patient, patient-derived brain-tumor initiating cell lines, tumor
Author NameAffiliation
Richard MarcellusOntario Institute for Cancer Research
David UehlingOntario Institute for Cancer Research
Ahmed AmanOntario Institute for Cancer Research
Jake Lever
Steven J M Jones
Steven J M JonesSimon Fraser University
Steven J M JonesUniversity of British Columbia
Steven J M Jones
Steven J M JonesUniversity of British Columbia
Steven J M JonesSimon Fraser University
Marco A Marra
Marco A MarraUniversity of British Columbia
Marco A Marra
Marco A MarraUniversity of British Columbia
Rima Al-AwarOntario Institute for Cancer Research
  • 1 - 15

Datasets

Release 1.2